Disc Medicine

Medscape members: Disc teamed up with Medscape to bring you an exclusive Med Ed webinar featuring our #ASH24 presentations on both BEACON and AURORA Phase 2 clinical trial results for #Bitopertin. Don’t miss this opportunity to explore key insights and advancements in #EPP and #XLP. Watch BEACON here: https://lnkd.in/eGQHFURZ Watch AURORA here: https://lnkd.in/ec7Tun5a

Thank you, BiotechTV, for spotlighting our #ASH24 positive clinical and translational data updates with CEO John Quisel! Learn more about the latest progress on bitopertin, DISC-0974, and DISC-3405 in the full video: https://lnkd.in/giB68Fz6

Today at the American Society of Hematology Annual Meeting, we will give an oral presentation on DISC-0974, highlighting progress in addressing #Anemia in #Myelofibrosis. We look forward to sharing this innovation with the #ASH24 community. Following the oral presentation, we will host a call to review highlights of all presented data at ASH and plans for next steps in development on Sunday, December 8, at 9:00pm EST / 6:00pm PST. Register now on the Events and Presentations page of our website: https://lnkd.in/gyWGHeMv

Disc will share data from across our portfolio in multiple presentations at the 2024 American Society of Hematology Annual Meeting! Join us in San Diego this December to explore innovations pushing the boundaries of hematology. Disc will host a call during the ASH meeting to review highlights of the presented data and plans for next steps in development on Sunday, December 8, at 9pm EST / 6pm PST. Read more: https://lnkd.in/eNsNd9_x #ASH24

Disc Medicine is excited to announce positive feedback from our end-of-Phase 2 meeting with the FDA, supporting the development path forward for bitopertin in #EPP and highlighting the potential for accelerated approval. Join us for our corporate call today at 8am ET. Read more: https://lnkd.in/eZzuF9TD

Just two weeks until Alfresco 2024 and we can’t wait! Thank you so much to our sponsors The National Lottery Community Fund, Disc Medicine, CLINUVEL PHARMACEUTICALS LTD, Alpkit Foundation, Coolibar - Technical. Elegant. Sun Protection You Wear.®, Mitsubishi Tanabe Pharma Corporation, and THE SOCIETY FOR THE STUDY OF INBORN ERRORS OF METABOLISM, for helping us provide sun-safe outdoor activities for children and young people affected by EPP 🌲 #PorphyriaTogether #RareDisease #CareForRare

We had so much fun with Adeline at Camp Sun Escape! Thank you to Disc Medicine, Victory Junction and our friends from Shadow Jumpers for making this camp possible for our EPP, XLP and CEP families. Can’t wait to do it again! https://lnkd.in/gf_6j3S9

A day free of #porphyria symptoms is the hope we share with every patient and caregiver. These stories from #PorphyriaPalooza inspire us to keep pushing for better treatments and brighter futures. #PorphyriaTogether #EPP #XLP

Thank you for visiting Disc HQ in Watertown, BiotechTV! Brad and CEO John Quisel discuss positive clinical data across all three programs from #EHA2024, including bitopertin for #EPP, DISC-0974 for #anemia of myelofibrosis, and DISC-3405 in healthy volunteers. Full conversation below: https://lnkd.in/eV3_wJ2D

Disc is thrilled to share positive clinical data across our portfolio at #EHA2024, including additional data for bitopertin in #EPP, updated data from our Phase 1b trial of DISC-0974 for MF #anemia, and initial SAD data from our Phase 1 trial of DISC-3405. Join us for our corporate call on Friday, June 14 at 8 am ET. Read more and register here: https://lnkd.in/eQshnEVw